Skip over navigation
Banner
Industry
Directory Facilities Technology Transfer Economic Develop. NH BioHistory (TM)
Career
Job Search Post a Job Destination NH
News/Events
Industry News Submit News Release Calendar Submit Event CEO Reading
Patient
Clinical Trials Drug Development Resources
Education
K-12 Higher Ed BioEd Reading
About
Advertising Feedback Home
News
 Industry News
 Submit News Release
 Calendar
 Submit Event
 CEO Reading
Quick Links
 Directory
 Job Search
 Facilities
 Calendar
 Advertising
 
Community Service Ad: The Norway Foundation
Want to target global biotech trade media?  Use B3C newswire  services.
 
Advertising
 
UW Master’s in Biomedical Regulatory Affairs: addressing devices, drugs & biologics. Apply now.

Industry News

UW Master’s in Biomedical Regulatory Affairs: addressing devices, drugs & biologics. Apply now.

Submit News Release


Search Articles: 

  • AMAG Pharmaceuticals announces appointment of two independent directors to its board  AMAG Pharma announced the appointment of Rajiv De Silva and Gino Santini to its board of directors. Mr. De Silva is currently president of Valeant Pharmaceuticals and COO of its Specialty Pharmaceuticals business. Mr. Santini retired in 2010 from a 27-year career at Eli Lilly and Company.
    February 07, 2012  
  • 3M increases dividend for the 54th consecutive year  The Board of Directors of 3M declared a dividend on the company’s common stock of 59 cents per share for the first quarter of 2012, a 7 percent increase over the quarterly dividend paid in 2011. The dividend is payable on March 12, 2012.
    February 07, 2012  
  • Harvard Bioscience acquires AHN Biotechnologie  Harvard Bioscience announced that it has acquired the business of AHN Biotechnologie GmbH through its wholly owned Biochrom Ltd. subsidiary. AHN is a privately held manufacturer of plastic consumable laboratory products including pipette tips.
    February 07, 2012  
  • Vyvanse® capsules now approved in the US for maintenance treatment in adults with ADHD  Shire announced the FDA approved the prescription medication Vyvanse® (lisdexamfetamine dimesylate) Capsules, as a maintenance treatment for adults with ADHD. The approval is based on results from a randomized withdrawal study designed to evaluate the efficacy of Vyvanse.
    February 07, 2012  
  • Administration announces new steps to fight Alzheimer’s disease  The Obama Administration announced new efforts to fight Alzheimer’s disease, including immediately making an additional $50 million available for cutting-edge research. In addition, the administration announced that its FY 2013 budget will boost funding for Alzheimer’s research by $80 million.
    February 07, 2012  
  • Sanofi announces FDA approval of Sklice® lotion for treatment of head lice  Sanofi announced that the FDA has approved Sklice® (ivermectin) lotion, 0.5% for the topical treatment of head lice, in patients 6 months of age and older. Effective and well-tolerated, Sklice Lotion treats lice in most patients with a single 10-minute application of the lotion.
    February 07, 2012  
  • Mayo Clinic study finds obesity affects severity of symptoms in fibromyalgia patients  People with fibromyalgia can have difficulty getting a definitive diagnosis and finding an effective treatment plan. One factor associated with fibromyalgia symptoms is a patient's weight, according to a Mayo Clinic study published in "Arthritis Care & Research."
    February 07, 2012  
  • Prometheus signs research & collaboration agreement with leading pharmaceutical company  Prometheus announced the execution of a research and collaboration agreement with an unnamed leading worldwide pharmaceutical company. The collaboration will use Prometheus’ proprietary oncology diagnostic platform (CEER) to develop diagnostic arrays relating to the partner’s oncology pipeline.
    February 07, 2012  
  • Lilly rcognized as a top company for executive women  Eli Lilly has earned a place on the NAFE "Top Companies for Executive Women" list for the fourth consecutive year. The 2012 list, compiled by the National Association for Female Executives, recognizes U.S. companies whose policies and practices encourage women's advancement.
    February 07, 2012  
  • Dow AgroSciences, BioDuro to collaborate on crop protection discovery research  Dow AgroSciences and BioDuro, a PPD® Company, announced a three-year, multi-program discovery research agreement to generate novel molecules for synthesizing and testing fungicides, insecticides, and herbicides across a variety of crops.
    February 07, 2012  

   (next 10 articles)

Submit News Release

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 2012 Info.Resource, Inc. All rights reserved.
Privacy Policy . Terms of Use . Advertising

NewHampshireLifeScience.com, owned and published by Info.Resource, Inc., is a resource
for the life science industry in the state of New Hampshire.